| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-08 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |